NEW ORLEANS, Sept. 12, 2017 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 16, 2017 to file lead plaintiff applications in a securities class action lawsuit against Blue Apron Holdings, Inc. (NYSE:APRN), if they purchased the Company’s securities pursuant to its June 29, 2017 initial public offering (“IPO”) and/or on the open market between June 29, 2017 and August 9, 2017. This action is pending in the United States District Court for the Eastern District of New York.
Get Help
Blue Apron investors should visit us at https://www.claimsfiler.com/cases/nyse-aprn or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Blue Apron and certain of its executives are charged with failing to disclose material information in its Registration Statement filed in connection with its IPO, violating federal securities laws.
The alleged false and misleading statements and omissions include, but are not limited to, that: (i) advertising spending was significantly reduced, despite prior statements to the contrary; (ii) delivery delays or defects were causing customer retention problems; (iii) the Company’s new facility launch was delayed; (iv) new product offerings were delayed; and (v) as a result of the foregoing, Blue Apron’s Registration Statement was materially false and misleading at all relevant times.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Italy Fines Apple €98.6 Million Over App Store Dominance
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 



